相似文献
1
Mouse Models of Antigen Presentation in Hematopoietic Stem Cell Transplantation.
Front Immunol. 2021 Sep 14;12:715893. doi: 10.3389/fimmu.2021.715893. eCollection 2021.
2
Alloantigen expression on non-hematopoietic cells reduces graft-versus-leukemia effects in mice.
J Clin Invest. 2010 Jul;120(7):2370-8. doi: 10.1172/JCI39165. Epub 2010 Jun 7.
3
HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study.
Front Immunol. 2020 Aug 20;11:1804. doi: 10.3389/fimmu.2020.01804. eCollection 2020.
4
Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.
Biol Blood Marrow Transplant. 2013 Aug;19(8):1244-53. doi: 10.1016/j.bbmt.2013.06.001. Epub 2013 Jun 10.
5
Minor histocompatibility antigens to predict, monitor or manipulate GvL and GvHD after allogeneic hematopoietic cell transplantation.
Best Pract Res Clin Haematol. 2024 Jun;37(2):101555. doi: 10.1016/j.beha.2024.101555. Epub 2024 May 15.
6
Alloantigen presentation and graft-versus-host disease: fuel for the fire.
Blood. 2016 Jun 16;127(24):2963-70. doi: 10.1182/blood-2016-02-697250. Epub 2016 Mar 30.
7
[Target antigens for graft-versus-host disease (GVHD) and graft-versus-leukemia/tumor (GVL/T)].
Nihon Rinsho. 2003 Sep;61(9):1512-9.
8
CD8+ but not CD4+ T cells require cognate interactions with target tissues to mediate GVHD across only minor H antigens, whereas both CD4+ and CD8+ T cells require direct leukemic contact to mediate GVL.
Blood. 2008 Apr 1;111(7):3884-92. doi: 10.1182/blood-2007-11-125294. Epub 2008 Jan 25.
9
H60: A Unique Murine Hematopoietic Cell-Restricted Minor Histocompatibility Antigen for Graft-versus-Leukemia Effect.
Front Immunol. 2020 Jun 10;11:1163. doi: 10.3389/fimmu.2020.01163. eCollection 2020.
10
Natural regulation of immunity to minor histocompatibility antigens.
J Immunol. 2007 Mar 15;178(6):3558-65. doi: 10.4049/jimmunol.178.6.3558.
引用本文的文献
1
Transplantation and Monitoring of a Murine Minor Histocompatibility Antigen-Mismatched Model of Graft-Versus-Host Disease.
Methods Mol Biol. 2025;2907:141-160. doi: 10.1007/978-1-0716-4430-0_7.
2
Graft-Versus-Host Disease Mouse Models: A Clinical-Translational Perspective.
Methods Mol Biol. 2025;2907:1-56. doi: 10.1007/978-1-0716-4430-0_1.
3
Epstein-Barr virus infection promotes T cell dysregulation in a humanized mouse model of multiple sclerosis.
Sci Adv. 2025 Mar 7;11(10):eadu5110. doi: 10.1126/sciadv.adu5110. Epub 2025 Mar 5.
4
AMPK drives both glycolytic and oxidative metabolism in murine and human T cells during graft-versus-host disease.
Blood Adv. 2024 Aug 13;8(15):4149-4162. doi: 10.1182/bloodadvances.2023010740.
5
Murine models of graft versus host disease (GVHD): Focus on ocular GVHD.
Ocul Surf. 2023 Oct;30:179-186. doi: 10.1016/j.jtos.2023.09.006. Epub 2023 Sep 22.
6
Endocan in Acute Leukemia: Current Knowledge and Future Perspectives.
Biomolecules. 2022 Mar 24;12(4):492. doi: 10.3390/biom12040492.
本文引用的文献
1
CD4CD8 T-Lymphocytes in Xenogeneic and Human Graft-versus-Host Disease.
Front Immunol. 2020 Nov 24;11:579776. doi: 10.3389/fimmu.2020.579776. eCollection 2020.
2
T cell exhaustion and a failure in antigen presentation drive resistance to the graft-versus-leukemia effect.
Nat Commun. 2020 Aug 24;11(1):4227. doi: 10.1038/s41467-020-17991-y.
3
The primacy of gastrointestinal tract antigen-presenting cells in lethal graft-versus-host disease.
Blood. 2019 Dec 12;134(24):2139-2148. doi: 10.1182/blood.2019000823.
4
Donor T-cell-derived GM-CSF drives alloantigen presentation by dendritic cells in the gastrointestinal tract.
Blood Adv. 2019 Oct 8;3(19):2859-2865. doi: 10.1182/bloodadvances.2019000053.
5
MHC Class II Antigen Presentation by the Intestinal Epithelium Initiates Graft-versus-Host Disease and Is Influenced by the Microbiota.
Immunity. 2019 Nov 19;51(5):885-898.e7. doi: 10.1016/j.immuni.2019.08.011. Epub 2019 Sep 18.
6
T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant.
Nat Med. 2019 Jul;25(7):1064-1072. doi: 10.1038/s41591-019-0472-9. Epub 2019 Jun 24.
7
Improved multilineage human hematopoietic reconstitution and function in NSGS mice.
PLoS One. 2018 Dec 12;13(12):e0209034. doi: 10.1371/journal.pone.0209034. eCollection 2018.
8
Lack of acute xenogeneic graft- versus-host disease, but retention of T-cell function following engraftment of human peripheral blood mononuclear cells in NSG mice deficient in MHC class I and II expression.
FASEB J. 2019 Mar;33(3):3137-3151. doi: 10.1096/fj.201800636R. Epub 2018 Nov 1.
9
Xenogeneic Graft-Versus-Host Disease in Humanized NSG and NSG-HLA-A2/HHD Mice.
Front Immunol. 2018 Aug 30;9:1943. doi: 10.3389/fimmu.2018.01943. eCollection 2018.
10
Comprehensive Analysis of the Activation and Proliferation Kinetics and Effector Functions of Human Lymphocytes, and Antigen Presentation Capacity of Antigen-Presenting Cells in Xenogeneic Graft-Versus-Host Disease.
Biol Blood Marrow Transplant. 2018 Aug;24(8):1563-1574. doi: 10.1016/j.bbmt.2018.04.016. Epub 2018 Apr 17.
Zotero 插件